SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2017 / Cilt: 17 - Sayı: 5

IRAK-4 Variants in acute coronary syndrome patients

HAYRİYE ARZU ERGEN
Osman FAZLIOĞULLARI
Cem BAŞARAN
Faruk ÇELİK
Gonca CANDAN
Özlem KAHRAMAN TİMİRCİ
ŞAKİR ÜMİT ZEYBEK
Pages
417–418
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ERGEN, H. A., FAZLIOĞULLARI, O., BAŞARAN, C., ÇELİK, F., CANDAN, G., TİMİRCİ, Ö. K., ZEYBEK, Ş. Ü. (2017). IRAK-4 Variants in acute coronary syndrome patients. The Anatolian Journal of Cardiology, Cilt: 17 - Sayı: 5, 417–418. https://ajindex.com/articles/365349

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Flego D, Severino A, Trotta F, Previtero M, Ucci S, Zara C, et al. Increased PTPN22 expression and defective CREB activation impair regulatory T-cell differentiation in non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2015; 65: 1175-86.
  2. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204-12. O\'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immun Rev 2008; 226: 10-8.
  3. Rekhter M, Staschke K, Estridge T, Rutherford P, Jackson N, GiffordMoore D. Genetic ablation of IRAK4 kinase activity inhibits vascular lesion formation. Biochem Biophys Res Commun 2008; 367: 642-8.
  4. Wyss CA, Neidhart M, Altwegg L, Spanaus KS, Yonekawa K, Wischnewsky MB. Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. Eur Heart J 2010; 31: 1457-69.